Pharmacological Inhibition of BAD Ser99 Phosphorylation Enhances the Efficacy of Cisplatin in Ovarian Cancer by Inhibition of Cancer Stem Cell-like Behavior

Pharmacological Inhibition of BAD Ser99 Phosphorylation Enhances the Efficacy of Cisplatin in Ovarian Cancer by Inhibition of Cancer Stem Cell-like Behavior

10.1021/acsptsci.0c00064

Saved in:

Bibliographic Details
Main Authors:	Wang, Yanxin, Chiou, Yi-Shiou, Chong, Qing-Yun, Zhang, Mengyi, Rangappa, Kanchuragoppal S, Ma, Lan, Zhu, Tao, Kumar, Alan Prem, Huang, Ruby Yun-Ju, Pandey, Vijay, Basappa, Lobie, Peter E
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Article
Language:	English
Published:	AMER CHEMICAL SOC 2023
Subjects:	Science & Technology Life Sciences & Biomedicine Chemistry, Medicinal Pharmacology & Pharmacy BAD phosphorylation NPB ovarian cancer cisplatin resistance cancer stem cell PHASE-III TRIAL INTERGROUP TRIAL CARBOPLATIN-PACLITAXEL 1ST-LINE TREATMENT SURVIVAL PROTEIN MECHANISMS THERAPY DEATH DRUG
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/245936
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Description
Summary:	10.1021/acsptsci.0c00064